Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation ...

Access to COVID-19 vaccines looks a little different for many Washingtonians, as federal guidance continues to shift and ...

The recommended schedule of standard childhood vaccines was recently reviewed and voted on by the CDC's revamped vaccine committee.

In a Q&A with STAT, Nobel winner Drew Weissman addressed concerns raised about Covid shots at a recent meeting of federal ...

The CDC's vaccine advisory board is reviewing vaccines after the panel was revamped by Robert F. Kennedy Jr., an anti-vaccine ...

The journey toward an RSV vaccine for children has been wrought with tragedy and setbacks. But six decades after scientists embarked on that path, they are nearing the finish line ...

Dr. Stephen Thomas, director of Upstate Global Health, discussed the recent changes to the childhood vaccine schedule, the ...

In response to a call from President Donald Trump to make the positive impact of Covid-19 vaccines public, drug giant Pfizer posted a collection of more than 200 news releases and statements and 27 ...

A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.

The CDC panel updates COVID-19 vaccine recommendations for 2024. Learn who is now eligible and what it means for your health.

Your family physician, primary care doctor, and pharmacist will also be able to walk you through the best available ...